MAM
JWT elevates Mohit Hira to head digital ops
Mumbai: JWT India has elevated Mohit Hira to head of its digital operations and he will be responsible for managing and growing JWT’s digital offering to clients across all markets in addition to his current responsibilities on Airtel.
He had joined JWT India last year as SVP and regional business director in Delhi.
Meanwhile, the current digital head at JWT India Max Hegerman is moving on to pursue other opportunities.
“As the new head of JWT Digital, he brings in long-term brand-building with rich digital experience, both online and offline. This, along with the ability to tap a rich eco-system of partners, like Hungama Digital Services and a global network that will bring the best of class for a client’s digital ambitions gives JWT Digital a unique advantage,” the company said.
Hira has over 26 years of experience in advertising, marketing, print and digital media. He had joined JWT from NIIT, where he was the President of the B2C global online learning business that he started. He was also the chief marketing officer for their retail individual training businesses and the NIIT University.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
